Meeder Asset Management Inc Avrobio, Inc. Transaction History

Meeder Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 02, 2020	SELL	$12.99 - $19.41 $39,086 - $58,404	-3,009 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$12.19 - $22.96 $32,571 - $61,349	2,672 Added 792.88%	3,009 $53,000
Q1 2020 May 15, 2020	SELL	$10.08 - $27.21 $20,129 - $54,338	-1,997 Reduced 85.56%	337 $5,000
Q4 2019 Feb 13, 2020	BUY	$13.05 - $21.88 $27,222 - $45,641	2,086 Added 841.13%	2,334 $47,000
Q3 2019 Oct 17, 2019	SELL	$14.12 - $23.44 $15,433 - $25,619	-1,093 Reduced 81.51%	248 $4,000
Q2 2019 Aug 05, 2019	BUY	$13.21 - $27.29 $17,714 - $36,595	1,341 New	1,341 $22,000

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.